UROPLASTY INC 4
4 · UROPLASTY INC · Filed Mar 6, 2014
Insider Transaction Report
Form 4
Transactions
- Sale
common stock
2014-03-04$4.03/sh−16,772$67,559→ 295,908 total - Sale
common stock
2014-03-05$3.95/sh−20,862$82,417→ 275,046 total - Sale
common stock
2014-03-06$3.92/sh−366$1,436→ 274,680 total
Holdings
- 100,000
non-qualified stock options
Exercise: $5.19From: 2006-02-02Exp: 2015-01-01→ common stock (100,000 underlying) - 4,100
non-qualified stock options
Exercise: $7.98From: 2012-06-07Exp: 2018-06-06→ common stock (4,100 underlying) - 6,525
non-qualified stock options
Exercise: $4.94From: 2011-06-08Exp: 2017-06-07→ common stock (6,525 underlying)
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.00 to $4.07 per share, inclusive. The reporting person undertakes to provide to Uroplasty, Inc., any security holder of Uroplasty, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1)
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.84 to $4.01 per share, inclusive. The reporting person undertakes to provide to Uroplasty, Inc., any security holder of Uroplasty, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2)
- [F3]Becomes exercisable with respect to one-third of the shares on the first, second and third anniversaries of the grant date (the grant date being one year prior to such date)
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.92 to $3.93 per share, inclusive. The reporting person undertakes to provide to Uroplasty, Inc., any security holder of Uroplasty, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (4)